Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 EPS Loss of $0.18

August 4, 2011 6:03 PM EDT Send to a Friend

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 EPS Loss of $0.18

Member Login

Free News Feed